Global Acute Kidney Injury Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Acute Kidney Injury Treatment Market Research Report 2024
Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure.
According to MRAResearch’s new survey, global Acute Kidney Injury Treatment market is projected to reach US$ 1633.3 million in 2033, increasing from US$ 1206.1 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Kidney Injury Treatment market research.
Key companies engaged in the Acute Kidney Injury Treatment industry include Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG and Angion Biomedica Corp, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Acute Kidney Injury Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Acute Kidney Injury Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acute Kidney Injury Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Quark Pharmaceuticals, Inc.
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
LG Chem
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Angion Biomedica Corp
Segment by Type
Prerenal Acute Kidney Injury
Postrenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acute Kidney Injury Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Acute Kidney Injury Treatment market is projected to reach US$ 1633.3 million in 2033, increasing from US$ 1206.1 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Kidney Injury Treatment market research.
Key companies engaged in the Acute Kidney Injury Treatment industry include Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG and Angion Biomedica Corp, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Acute Kidney Injury Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Acute Kidney Injury Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acute Kidney Injury Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Quark Pharmaceuticals, Inc.
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
LG Chem
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Angion Biomedica Corp
Segment by Type
Prerenal Acute Kidney Injury
Postrenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acute Kidney Injury Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source